Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
Department of Health and Human Services
Description
Opportunity: NICHD (NIH) funding to develop or improve technologies that boost fertility outcomes, especially in assisted reproductive technologies (ART). Aimed at moving validated, innovative ideas toward future clinical development.
Why it matters: Infertility affects about 15% of couples, with male and female factors contributing equally. ART use has doubled in the last decade but succeeds only ~33% of the time. Better, more cost-effective solutions are needed.
The purpose of this NOFO is to support and facilitate multidisciplinary research approaches for the development or improvement of technologies - including drugs, devices, products, or clinical practices - designed to improve fertility outcomes in patients dealing with infertility, particularly i…
Source
Grant ID
RFA:RFA-HD-26-001.html
Agency
Department of Health and Human Services
Similar opportunities
- Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
Department of Health and Human Services
- Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
Department of Health and Human Services
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health